Home » Topics » BioWorld Science

BioWorld Science
RSS

First patient dosed in phase I/II study of TJD5 in China

May 14, 2020

Discovery of potent BACE1 inhibitor, AM-6494

May 14, 2020

TBR-760 results in complete arrested tumor growth in mouse model of NFPA

May 14, 2020

Phase I data presented for LC51-0255

May 14, 2020

Immunity-related pathways contribute to the genetic burden of asthma pathology, new GWAS shows

May 14, 2020

Copper escort alleviates Menkes disease

May 14, 2020

New compounds target SARS-CoV-2 main protease Mpro

May 13, 2020

TransThera studies TT-00920 for heart failure in first-in-human study

May 13, 2020

Veru cleared by FDA to begin phase II study of VERU-111 for COVID-19

May 13, 2020

Arrowhead opens enrollment in phase Ib study of ARO-HIF2 in advanced clear cell renal cell carcinoma

May 13, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...